Immuron Limited (IMRN)
Immuron Limited (IMRN)
$2.75 USD
Updated Sep 20 11:31am
Add IMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
IMRN Stock Chart More Charts
IMRN Price/Volume Stats
| Current price | $2.75 |
| Prev. close | $2.75 |
| Day low | $2.75 |
| Day high | $2.80 |
| 50-day MA | $3.04 |
| 200-day MA | $5.20 |
| 52-week high | $10.11 |
| 52-week low | $2.23 |
| Volume | 3,235 |
| Avg. volume | 103,293 |
| Dividend yield | N/A |
| Market Cap | 9.85M |
Immuron Limited (IMRN) Company Bio
Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.
Top Stories View All
Best & Worst Performing Stock Industries for September 19, 2019
Best & Worst Performing Small Cap Stocks for September 19, 2019
Best & Worst Performing Mid Cap Stocks for September 19, 2019
Best & Worst Performing Large Cap Stocks for September 19, 2019
Best & Worst Performing Mega Cap Stocks for September 19, 2019
View All Top Stories
Loading social stream, please wait...